ActivBiotics' Series A Round

ActivBiotics raised a round of funding on September 19, 2001.

ActivBiotics is focused on the development and commercialization of antibacterials for the treatment of acute and chronic disease. The Company is developing rifalazil - a potent broad spectrum antibio…

Articles about ActivBiotics' Series A Round: